Alkyne CPG modifier 500
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
12860 | 100 mg | $60.00 | in stock | |
22860 | 250 mg | $120.00 | in stock | |
32860 | 500 mg | $230.00 | in stock | |
42860 | 1 g | $380.00 | in stock | |
52860 | 5 g |
$1450.00
|
in stock |
High loading controlled pore glass solid support for the synthesis of oligonucleotides with 3'-alkyne group. With this solid support, synthesis of oligos of up to 50 bases is possible.
Terminal alkyne group can be modified by copper catalyzed Click chemistry (see our recommended protocol for oligonucleotide modification).
This solid support is compatible with standard oligonucleotide deblocking conditions. No special deblocking is required.
Customers also purchased with this product
TFA-aminolinker C6 phosphoramidite
Trifluoroacetyl protected aminolink C6 phosphoramidite for the synthesis of amino-modified oligonucleotides.Alkyne dT phosphoramidite
Phosphoramidite modifier for the synthesis of oligonucleotides containing alkyne modification in the middle of the chain.get free express delivery
get free express delivery
General properties
Appearance: | off-white beads |
Quality control: | NMR 1H and HPLC (95%) of bound reagent, loading measurement |
Storage conditions: | Storage: 24 months after receival at -20°C. Transportation: at room temperature for up to 3 weeks. Desiccate. |
MSDS: | Download |
Product specifications |
Oligo synthesis details
Pore size, Å: | 500 |
Typical loading, umol/g: | 70−90 |
Coupling conditions: | standard coupling, identical to normal nucleobases |
Cleavage conditions: | ammonia, 2 h at room temperature |
Deprotection conditions: | identical to protected nucleobases |
Product citations
- Petrunina, N.A.; Lebedev, V.V.; Kirillova, Y.G.; Aralov, A..V.; Varizhuk, A.M.; Sardushkin, M.V. DNA Intercalated Motifs with Non-Nucleoside Inserts. Russian Journal of Bioorganic Chemistry, 2021, 47(6), 1341–1344. doi: 10.1134/S1068162021060212
- Svetlova, J.; Sardushkin, M.; Kolganova, N.; Timofeev, E. Recognition Interface of the Thrombin Binding Aptamer Requires Antiparallel Topology of the Quadruplex Core. Biomolecules, 2021, 11(9), 1332. doi: 10.3390/biom11091332
